MacroGenics Inc (MGNX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: MGNX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2018-01-18	2018-01-17	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Officer	2,524 -7.8% 20.00 50,480 USD	2,524 -7.8%	20.00	50,480 USD
2018-01-18	2018-01-16	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Officer	2,476 -7.6% 20.00 49,520 USD	2,476 -7.6%	20.00	49,520 USD
2017-11-21	2017-11-21	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Dev. & CMO	5,000 -14.3% 20.00 100,000 USD	5,000 -14.3%	20.00	100,000 USD
2017-10-26	2017-10-25	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Dev. & CMO	10,000 -25.0% 20.00 200,000 USD	10,000 -25.0%	20.00	200,000 USD
2017-06-06	2017-06-05	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Dev. & CMO	5,000 -14.3% 20.00 100,000 USD	5,000 -14.3%	20.00	100,000 USD
2017-04-20	2017-04-19	S Sale	Wigginton Jon Marc Sr VP, Clinical Dev. & CMO	15,000 -33.3% 20.00 300,000 USD	15,000 -33.3%	20.00	300,000 USD
2016-10-05	2016-10-03	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Officer	10,000 -100.0% 29.34 293,400 USD	10,000 -100.0%	29.34	293,400 USD
2016-10-05	2016-10-03	PS Planned sale	Cilinski Lynn VP, Controller and Treasurer Officer	6,231 -76.4% 29.28 182,444 USD	6,231 -76.4%	29.28	182,444 USD
2016-08-03	2016-08-01	PS Planned sale	Wigginton Jon Marc Sr VP Clinical Dev & CMO Officer	20,000 -100.0% 30.78 615,600 USD	20,000 -100.0%	30.78	615,600 USD
2016-07-06	2016-07-01	PS Planned sale	Wigginton Jon Marc Sr VP Clinical Dev & CMO Officer	5,000 -100.0% 27.22 136,100 USD	5,000 -100.0%	27.22	136,100 USD
2016-07-06	2016-07-01	PS Planned sale	Cilinski Lynn VP, Controller and Treasurer Officer	8,922 -82.3% 27.22 242,857 USD	8,922 -82.3%	27.22	242,857 USD
2016-05-27	2016-05-27	PS Planned sale	Cilinski Lynn VP, Controller and Treasurer Officer	5,000 -72.2% 25.00 125,000 USD	5,000 -72.2%	25.00	125,000 USD
2016-03-04	2016-03-03	B Purchase	Costa Paulo F Non-Executive Director	10,000 +20.2% 17.20 172,000 USD	10,000 +20.2%	17.20	172,000 USD
2016-01-06	2016-01-04	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Officer	10,000 -100.0% 29.64 296,400 USD	10,000 -100.0%	29.64	296,400 USD
2015-11-24	2015-11-23	PS Planned sale	Cilinski Lynn VP, Controller and Treasurer Officer	1,921 -50.0% 35.00 67,235 USD	1,921 -50.0%	35.00	67,235 USD
2015-11-24	2015-11-23	PS Planned sale	Cilinski Lynn VP, Controller and Treasurer Officer	3,815 -49.8% 35.00 133,525 USD	3,815 -49.8%	35.00	133,525 USD
2015-11-24	2015-11-23	PS Planned sale	Cilinski Lynn VP, Controller and Treasurer Officer	1,185 -23.6% 35.00 41,475 USD	1,185 -23.6%	35.00	41,475 USD
2015-10-02	2015-10-01	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Officer	5,000 -100.0% 21.11 105,550 USD	5,000 -100.0%	21.11	105,550 USD
2015-08-03	2015-08-03	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Officer	10,000 -100.0% 37.15 371,500 USD	10,000 -100.0%	37.15	371,500 USD
2015-07-13	2015-07-10	PS Planned sale	Bonvini Ezio Senior VP, Research Officer	2,400 -6.1% 38.09 91,416 USD	2,400 -6.1%	38.09	91,416 USD
2015-07-01	2015-07-01	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Officer	5,000 -100.0% 37.15 185,750 USD	5,000 -100.0%	37.15	185,750 USD
2015-07-01	2015-07-01	PS Planned sale	Cilinski Lynn VP, Controller and Treasurer Officer	1,921 -33.3% 37.15 71,365 USD	1,921 -33.3%	37.15	71,365 USD
2015-07-01	2015-07-01	PS Planned sale	Cilinski Lynn VP, Controller and Treasurer Officer	5,000 -46.4% 37.15 185,750 USD	5,000 -46.4%	37.15	185,750 USD
2015-07-01	2015-06-30	PS Planned sale	Bonvini Ezio Senior VP, Research Officer	6,497 -15.0% 38.07 247,341 USD	6,497 -15.0%	38.07	247,341 USD
2015-06-16	2015-06-15	PS Planned sale	Cilinski Lynn VP, Controller and Treasurer Officer	5,700 -49.7% 35.00 199,500 USD	5,700 -49.7%	35.00	199,500 USD
2015-06-16	2015-06-15	PS Planned sale	Cilinski Lynn VP, Controller and Treasurer Officer	5,000 -30.4% 35.00 175,000 USD	5,000 -30.4%	35.00	175,000 USD
2015-06-16	2015-06-15	S Sale	Bonvini Ezio Senior VP, Research Officer	6,233 -14.5% 34.01 211,984 USD	6,233 -14.5%	34.01	211,984 USD
2015-05-18	2015-05-15	S Sale	Bonvini Ezio Senior VP, Research Officer	6,233 -14.5% 30.24 188,486 USD	6,233 -14.5%	30.24	188,486 USD
2015-04-16	2015-04-15	PS Planned sale	Bonvini Ezio Senior VP, Research Officer	6,233 -14.5% 33.98 211,797 USD	6,233 -14.5%	33.98	211,797 USD
2015-04-03	2015-04-01	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Officer	5,000 -100.0% 30.86 154,300 USD	5,000 -100.0%	30.86	154,300 USD
2015-02-03	2015-02-02	PS Planned sale	Wigginton Jon Marc Sr VP, Clinical Officer	5,000 -100.0% 31.04 155,200 USD	5,000 -100.0%	31.04	155,200 USD
2014-12-23	2014-12-22	PS Planned sale	Stein Kathryn E SVP, Product Dev. & Regulatory Officer	10,946 -20.2% 37.00 405,002 USD	10,946 -20.2%	37.00	405,002 USD
2014-12-22	2014-12-18	PS Planned sale	Risser Eric Blasius VP, Business Development Officer	10,000 -100.0% 33.50 335,000 USD	10,000 -100.0%	33.50	335,000 USD
2014-12-22	2014-12-18	PS Planned sale	Stein Kathryn E SVP, Product Dev. & Regulatory Officer	10,946 -20.2% 33.00 361,218 USD	10,946 -20.2%	33.00	361,218 USD
2014-11-25	2014-11-24	PS Planned sale	Risser Eric Blasius VP, Business Development Officer	10,000 -100.0% 27.75 277,500 USD	10,000 -100.0%	27.75	277,500 USD
2014-11-24	2014-11-21	PS Planned sale	Stein Kathryn E Senior VP, Prd Dev & Reg Aff Officer	10,946 -20.2% 27.00 295,542 USD	10,946 -20.2%	27.00	295,542 USD
2014-11-17	2014-11-17	PS Planned sale	Stein Kathryn E Senior VP, Prd Dev & Reg Aff Officer	2,090 -4.6% 22.95 47,966 USD	2,090 -4.6%	22.95	47,966 USD
2014-11-17	2014-11-14	PS Planned sale	Stein Kathryn E Senior VP, Prd Dev & Reg Aff Officer	23,211 -34.9% 23.33 541,513 USD	23,211 -34.9%	23.33	541,513 USD
2014-11-13	2014-11-13	PS Planned sale	Risser Eric Blasius VP, Business Development Officer	10,000 -100.0% 25.00 250,000 USD	10,000 -100.0%	25.00	250,000 USD
2014-11-13	2014-11-12	PS Planned sale	Risser Eric Blasius VP, Business Development Officer	15,000 -100.0% 23.00 345,000 USD	15,000 -100.0%	23.00	345,000 USD
2014-10-02	2014-10-01	S Sale	Wigginton Jon Marc Sr V.P., Clinical Officer	5,000 -100.0% 20.48 102,400 USD	5,000 -100.0%	20.48	102,400 USD
2014-08-19	2014-08-18	PS Planned sale	Wigginton Jon Marc Senior VP, Clinical Dev. Officer	5,000 -100.0% 20.52 102,600 USD	5,000 -100.0%	20.52	102,600 USD
2014-07-01	2014-06-30	PS Planned sale	Risser Eric Blasius VP, Business Development Officer	8,000 -37.5% 21.84 174,720 USD	8,000 -37.5%	21.84	174,720 USD
2014-05-30	2014-05-29	S Sale	Stein Kathryn E Senior VP, Prd Dev & Reg Aff Officer	10,946 -20.2% 19.75 216,184 USD	10,946 -20.2%	19.75	216,184 USD
2014-02-18	2014-02-18	S Sale	ORONSKY ARNOLD L Non-Executive Director	200,000 -10.5% 36.50 7,300,000 USD	200,000 -10.5%	36.50	7,300,000 USD
2014-02-18	2014-02-18	S Sale	HURWITZ EDWARD Non-Executive Director	308,513 -15.3% 36.50 11,260,725 USD	308,513 -15.3%	36.50	11,260,725 USD
2013-10-18	2013-10-16	B Purchase	Galbraith Kenneth Non-Executive Director	46,875 +inf% 16.00 750,000 USD	46,875 +inf%	16.00	750,000 USD